News | News By Subject | News by Disease News By Date | Search News

Infection/Antibiotics News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Warp Drive Bio Hands Over Antibiotics Program to Sanofi (SNY)     11/30/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials     10/25/2016
A Closer Look at the Pipelines Pfizer (PFE) Inherited From Recent Acquisitions     10/5/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072     8/15/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales     7/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set     7/22/2016
FDA Spurns Novartis AG (NVS)'s Copy of Amgen (AMGN) Blockbuster Neulasta     7/19/2016
FDA Advisors Backs Approval for Merck & Co. (MRK)'s Infectious Diarrhea Drug     6/10/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy     6/8/2016
FDA Warns Against Off-Label Use of Johnson & Johnson (JNJ)'s Nizoral Tablets to Treat Skin And Nail Infections, Linked to Patient Death     5/20/2016
TetraPhase (TTPH) Drops After the FDA Requests More Data for Eravacycline NDA Submission     5/13/2016
More Bad News for Chimerix (CMRX) as Brincidofovir Fails Another Late Stage Study     5/9/2016
Basilea (BSLN.SW) Wins $100 Million Contract to Fund Phase III Ceftobiprole Program     4/20/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge     4/14/2016

News from Around the Web
New Test Can ID Dangerous Bacteria With Resistance To Last-Resort Antibiotic, European Society of Clinical Microbiology and Infectious Diseases Reveals     4/24/2017
Can Maple Syrup Extract Make Antibiotics Kill Bacteria Easily? McGill University Study Reveals     4/5/2017
Common Antibiotic May Help To Prevent Or Treat PTSD, University of Zurich Study Reveals     4/4/2017
Who Is On The WHO's New Most Dangerous Superbugs List     2/28/2017
Woman Dies Of A Superbug Resistant To Every Antibiotic In The U.S., CDC Study     1/13/2017
From Click Chemistry To Antibiotic Spider Silk, University of Nottingham Study     1/9/2017
Portable Antibiotic Resistance Detector Developed, UCLA Study     12/27/2016
New Tool May Help Combat Antibiotic Resistance, University of Sheffield Study     11/1/2016
Scientists Are Freaking Out Over This 25-Year-Old's Solution To Superbugs, University Of Montreal Study     9/28/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
Saving Antibiotics So That Antibiotics Can Save Lives     9/16/2016
Kids With Exposure To Antibiotics Linked To Allergies Later In Life, Utrecht University Study     9/6/2016
Rapid Bacterial Infection Test Reduces Antibiotic Use, University of Oxford Study     8/3/2016
A Potential Lifesaver Lies Unrecognized In The Human Body, University of Tubingen Study     7/28/2016
Infections, Antibiotic Use Linked To Manic Episodes In People With Serious Mental Illness, Johns Hopkins University School of Medicine Study     7/21/2016

Press Releases
Summit Therapeutics Presents Data From Phase I Clinical Programme Of Ezutromid At The EPNS Congress     6/22/2017
Melinta Announces FDA Approval Of Baxdela (Delafloxacin) For Acute Bacterial Skin And Skin Structure Infections (ABSSSI)     6/20/2017
RedHill Biopharma (RDHL) Announces Confirmatory Phase III Study Initiated With RHB-105 (TALICIA) For H. Pylori Infection     6/15/2017
New Study Further Demonstrates In Vitro Activity Of SCYNEXIS, Inc. (SCYX)’ Lead Anti-Infective Candidate, SCY-078, Against Drug-Resistant Candida Fungal Strains     6/15/2017
Actelion (ALIOF.PK) Reports Good And Bad News For Phase III CDAD Trials     6/8/2017
Ultra-Sensitive C. Difficile Assay In Development By Singulex Demonstrates Potential To Improve Diagnosis In Pilot Studies     6/6/2017
Zavante Therapeutics Reports ZOLYD Broad Spectrum Activity And Synergy With Multiple Antibiotics; In Vitro Studies Presented At ASM Microbe 2017 Meeting     6/5/2017
Matinas BioPharma Announces Interim Data From NIH-Conducted Phase IIa Clinical Study Of Orally-Administered MAT2203 For The Treatment Of Chronic Refractory Mucocutaneous Candidiasis     6/5/2017
SCYNEXIS, Inc. (SCYX) Release: Eight Presentations At ASM Microbe 2017 Further Highlight The Strong Antifungal Effect And Promising Safety Profile Of Lead Anti-Infective Candidate SCY-078     6/5/2017
Achaogen (AKAO) Highlights Data Demonstrating Potential Of Plazomicin Against MDR Gram-Negative Bacteria At ASM Microbe 2017 Annual Meeting     6/5/2017
TetraPhase (TTPH) Announces Positive Phase I Single-Ascending Dose Data For Antibiotic Pipeline Candidates     6/5/2017
Summit Therapeutics Presents Positive New Preclinical Data On Novel CDI Antibiotic Ridinilazole At ASM Microbe 2017     6/5/2017
Eight Presentations At ASM Microbe Include Late Breaker From Cempra (CEMP)’s Phase III Fusidic Acid Study And Solithromycin Data On Gonorrhea And Otitis Media     6/2/2017
Achaogen (AKAO) Initiates C-Scape Clinical Development Program With Phase I Study Of Orally-Administered Antibacterial Candidate     6/1/2017
Achaogen (AKAO) Release: Plazomicin Granted FDA Breakthrough Therapy Designation     5/24/2017

//-->